BNC · BNB Standard Corp · Insider Trading

The exercise price is $0.00001 per share.

This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

The exercise price is $0.00001 per share.

This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

The exercise price is $0.00001 per share.

The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.

Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the "Beneficial Ownership Limitations"), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.

This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

The exercise price is $0.00001 per share.

The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the "SAW Beneficial Ownership Limitation"). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.

Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the "Beneficial Ownership Limitations"), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.

This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

RSUs convert into common stock on a one-for-one basis.

25% of the RSUs (90,909 shares) vest on April 6, 2027, with the remaining RSUs vesting in equal quarterly installments thereafter through April 6, 2030, subject to the Participant's continued service with the Company through each applicable vesting date. The RSUs were granted pursuant to the CEA Industries Inc. 2026 Inducement Plan.

Reflects the effective assignment of such warrants to a third-party.

Reporting Person is the manager of 10X Capital Partners LLC and may be deemed to have beneficial ownership of the securities held by 10X Capital Partners LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the exercise of certain warrants for shares of common stock.

Reporting Person is the manager of 10X LLC and may be deemed to have beneficial ownership of the securities held by 10X LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the exercise of certain warrants for shares of common stock.

Reporting Person is the manager of 10X LLC and may be deemed to have beneficial ownership of the securities held by 10X LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

RSUs convert into common stock on a one-for-one basis.

Represents the grant of 2,660 RSUs issued pursuant to the Company's compensation plan for independent directors effective December 16, 2024, and subject to the terms and restrictions of the Agreement.

1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

RSUs convert into common stock on a one-for-one basis.

Represents the grant of 2,660 RSUs issued pursuant to the Company's compensation plan for independent directors effective December 16, 2024, and subject to the terms and restrictions of the Agreement.

1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

On October 7, 2025, 1,330 restricted stock units ("RSUs") were vested in accordance with the vesting schedule in the Restricted Stock Unit Agreement ("Agreement").

RSUs convert into common stock on a one-for-one basis.

1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

On October 7, 2025, 1,330 restricted stock units ("RSUs") were vested in accordance with the vesting schedule in the Restricted Stock Unit Agreement ("Agreement").

RSUs convert into common stock on a one-for-one basis.

1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

Represents the weighted average price of the shares purchased on the open market. The prices of the shares purchased pursuant to the transaction ranged from $8.52 to $8.70 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

On October 1, 2025, 10X BNB Cayman Sponsor transferred and assigned 100% of its Strategic Advisor Warrants to certain members of 10X BNB Cayman Sponsor and third-parties, resulting in 10X BNB Cayman Sponsor beneficially owning no warrants following the transaction. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reporting Person was the manager of 10X BNB Cayman Sponsor and may be deemed to have beneficial ownership of the securities held by 10X BNB Cayman Sponsor. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

On October 1, 2025, 10X LLC received 831,683 Strategic Advisor Warrants that were assigned from 10X BNB Cayman Sponsor. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reporting Person is the manager of 10X LLC and may be deemed to have beneficial ownership of the securities held by 10X LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Reflects the effective assignment of such warrants to a third-party.

Reporting Person is the manager of 10X Capital Partners LLC and may be deemed to have beneficial ownership of the securities held by 10X Capital Partners LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

Represents the grant of 5,790 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

Represents the grant of 96,507 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

The Restricted Stock Units will vest on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

Represents the grant of 223,125 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity retention award.

The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

Represents the grant of 40,533 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

The Restricted Stock Units will vest on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

Represents the grant of 119,669 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity retention award.

Represents shares of common stock issued on vesting of restricted stock units reported on Table II of Form 4, dated January 2, 2024, of the reporting person.

Represents the grant of 45,455 restricted stock units which vested on the date of grant. These shares were granted as an equity retention award in connection with the Reporting Person's service as an independent director of the Issue.

Represents the grant of 45,455 restricted stock units which vested on the date of grant. These shares were granted as an equity retention award in connection with the Reporting Person's service as an independent director of the Issue.

Represents shares of common stock issued on vesting of restricted stock units reported on Table II of Form 4, dated January 2, 2024, of the reporting person.

Represents the grant of 45,455 restricted stock units which vested on the date of grant. These shares were granted as an equity retention award in connection with the Reporting Person's service as an independent director of the Issue.

Represents shares of common stock issued on vesting of restricted stock units reported on Table II of Form 4, dated January 2, 2024, of the reporting person.